Cargando…

Hypoxia and Microvascular Alterations Are Early Predictors of IDH-Mutated Anaplastic Glioma Recurrence

SIMPLE SUMMARY: Anaplastic gliomas (AGs) are considered the most common and aggressive primary brain tumors of young adults with inevitable recurrence and treatment failure. The aim of this study was to investigate whether the imaging biomarkers of hypoxia, microvascular architecture and neovascular...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stadlbauer, Andreas, Oberndorfer, Stefan, Heinz, Gertraud, Zimmermann, Max, Kinfe, Thomas M., Doerfler, Arnd, Buchfelder, Michael, Kremenevski, Natalia, Marhold, Franz
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8068871/ https://www.ncbi.nlm.nih.gov/pubmed/33918764 http://dx.doi.org/10.3390/cancers13081797

Ejemplares similares

Physiological MRI of microvascular architecture, neovascularization activity, and oxygen metabolism facilitate early recurrence detection in patients with IDH-mutant WHO grade 3 glioma
por: Stadlbauer, Andreas, et al.
Publicado: (2021)

Metabolic Tumor Microenvironment Characterization of Contrast Enhancing Brain Tumors Using Physiologic MRI
por: Stadlbauer, Andreas, et al.
Publicado: (2021)

Vascular Hysteresis Loops and Vascular Architecture Mapping in Patients with Glioblastoma treated with Antiangiogenic Therapy
por: Stadlbauer, Andreas, et al.
Publicado: (2017)

Radiophysiomics: Brain Tumors Classification by Machine Learning and Physiological MRI Data
por: Stadlbauer, Andreas, et al.
Publicado: (2022)

Physiological MRI Biomarkers in the Differentiation Between Glioblastomas and Solitary Brain Metastases
por: Heynold, Elisabeth, et al.
Publicado: (2021)

Differentiation of Glioblastoma and Brain Metastases by MRI-Based Oxygen Metabolomic Radiomics and Deep Learning
por: Stadlbauer, Andreas, et al.
Publicado: (2022)

Advanced MRI in neuro-oncology: can we proceed without inclusion of energy metabolism?
por: Stadlbauer, Andreas, et al.
Publicado: (2019)

The Diagnostic and Therapeutic Role of Leptin and Its Receptor ObR in Glioblastoma Multiforme
por: Kinfe, Thomas M., et al.
Publicado: (2020)

Estimation of the occurrence rates of IDH1 and IDH2 mutations in gliomas and the reconsideration of IDH-wildtype anaplastic astrocytomas: an institutional experience
por: Cho, Uiju, et al.
Publicado: (2021)

Comparative fMRI and MEG localization of cortical sensorimotor function: Bimodal mapping supports motor area reorganization in glioma patients
por: Zimmermann, Max, et al.
Publicado: (2019)

Cutaneous Microvascular Blood Flow and Reactivity in Hypoxia
por: Treml, Benedikt, et al.
Publicado: (2018)

CyTOF Analysis Reveals a Distinct Immunosuppressive Microenvironment in IDH Mutant Anaplastic Gliomas
por: Fu, Weilun, et al.
Publicado: (2021)

Large tumour volume reduction of IDH-mutated anaplastic glioma involving the insular region following radiotherapy
por: Metz, Gabrielle, et al.
Publicado: (2022)

Intracranial Germinomas: Diagnosis, Pathogenesis, Clinical Presentation, and Management
por: Kremenevski, Natalia, et al.
Publicado: (2023)

Melatonin Moderates the Triangle of Chronic Pain, Sleep Architecture and Immunometabolic Traffic
por: Chaudhry, Shafqat R., et al.
Publicado: (2021)

Identification of a Prognostic Hypoxia-Associated Gene Set in IDH-Mutant Glioma
por: Dao Trong, Philip, et al.
Publicado: (2018)

Therapies for IDH-Mutant Gliomas
por: Alshiekh Nasany, Ruham, et al.
Publicado: (2023)

Immunometabolic Profiling of Chronic Subdural Hematoma through Untargeted Mass Spectrometry Analysis: Preliminary Findings of a Novel Approach
por: Kipele, Maria, et al.
Publicado: (2023)

Postoperative risk of IDH-mutant glioma–associated seizures and their potential management with IDH-mutant inhibitors
por: Drumm, Michael R., et al.
Publicado: (2023)

The prognostic role of IDH mutations in homogeneously treated patients with anaplastic astrocytomas and glioblastomas
por: Christians, Arne, et al.
Publicado: (2019)

The comparison of clinical and biological characteristics between IDH1 and IDH2 mutations in gliomas
por: Wang, Hao-Yuan, et al.
Publicado: (2016)

DDRE-12. HETEROGENOUS RESPONSE OF IDH-MUTANT AND IDH-WT GLIOMA TO NAMPT INHIBITION
por: Rahman, Masum, et al.
Publicado: (2021)

Data fusion and 3D visualization for optimized representation of neurovascular relationships in the posterior fossa
por: Hastreiter, Peter, et al.
Publicado: (2022)

Improved Detection of Cavernous Sinus Invasion of Pituitary Macroadenomas with Ultra-High-Field 7 T MRI
por: Eisenhut, Felix, et al.
Publicado: (2022)

Characteristics of gliomas in patients with somatic IDH mosaicism
por: Bonnet, Charlotte, et al.
Publicado: (2016)

Retrospective examination of pseudoprogression in IDH mutant gliomas
por: Wetzel, Ethan A, et al.
Publicado: (2023)

Stalled oligodendrocyte differentiation in IDH-mutant gliomas
por: Wei, Yanfei, et al.
Publicado: (2023)

Updates on the WHO diagnosis of IDH-mutant glioma
por: Reuss, David.E.
Publicado: (2023)

IDH1 Mutation in Brain Stem Glioma: Case Report and Review of Literature
por: Javadi, Seyed Amirhossein, et al.
Publicado: (2018)

Burst Motor Cortex Stimulation Evokes Sustained Suppression of Thalamic Stroke Pain: A Narrative Review and Single-Case Overview
por: Nüssel, Martin, et al.
Publicado: (2020)

Real-time imaging of glutamate transients in the extracellular space of acute human brain slices using a single-wavelength glutamate fluorescence nanosensor
por: Brandner, Sebastian, et al.
Publicado: (2022)

Deep Brain Stimulation, Stereotactic Radiosurgery and High-Intensity Focused Ultrasound Targeting the Limbic Pain Matrix: A Comprehensive Review
por: Nüssel, Martin, et al.
Publicado: (2022)

Multicenter DSC–MRI-Based Radiomics Predict IDH Mutation in Gliomas
por: Manikis, Georgios C., et al.
Publicado: (2021)

Consequences of IDH1/2 Mutations in Gliomas and an Assessment of Inhibitors Targeting Mutated IDH Proteins
por: Kaminska, Bozena, et al.
Publicado: (2019)

Methylation and transcription patterns are distinct in IDH mutant gliomas compared to other IDH mutant cancers
por: Unruh, Dusten, et al.
Publicado: (2019)

Wild-Type IDH1 and Mutant IDH1 Opposingly Regulate Podoplanin Expression in Glioma()()
por: Sun, Chao, et al.
Publicado: (2020)

CBMS-1 Targeting amino acid metabolic vulnerabilities in IDH-mutant and IDH-wildtype gliomas
por: Ohba, Shigeo, et al.
Publicado: (2021)

Isocitrate Dehydrogenase IDH1 and IDH2 Mutations in Human Cancer: Prognostic Implications for Gliomas
por: Murugan, A. K., et al.
Publicado: (2022)

Implications of Cellular Immaturity in Necrosis and Microvascularization in Glioblastomas IDH-Wild-Type
por: Orasanu, Cristian Ionut, et al.
Publicado: (2022)

IDH1(R132H) Mutation Increases U87 Glioma Cell Sensitivity to Radiation Therapy in Hypoxia
por: Wang, Xiao-Wei, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_b04tmf4jt90lbv845aonb8of0m